Kiers Jeroen Lucas, Bult Johannes Hendrikus Franciscus
JLK Nutrition, Amersfoort, The Netherlands.
Applegg, Amersfoort, The Netherlands.
J Med Food. 2021 Mar;24(3):292-298. doi: 10.1089/jmf.2020.0034. Epub 2020 Jul 2.
Poor joint health is a significant burden to society. Millions of people suffer from some form of joint-related disorder or disease, most often osteoarthritis (OA). It was hypothesized that chicken eggshell membrane (EM) is effective in the regeneration of cartilage and/or immunomodulation (oral tolerance), and as such relieves pain and stiffness in joints commonly affected in arthritis. We tested this hypothesis in a double-blind, placebo-controlled EM intervention study. Of 150 male and female volunteers, 40-75 years of age and diagnosed with knee OA, 75 were randomly assigned to the EM intervention group and 75 to the placebo group. During 12 weeks, subjects received a daily capsule containing either 300 mg of EM or a placebo. The main primary dependent variable consisted of self-reported pain ratings on a Numerical Rating Scale Pain (NRS-P) 6 weeks after study start. As secondary dependent variables served NRS-P scores collected after 12 weeks, and Knee injury and self-reported Osteoarthritis Outcome Scores (Knee injury and Osteoarthritis Outcome Scores [KOOS]). NRS-P scores decreased for both groups at approximately the same rate, but only EM relieved self-reported pain scores obtained with the KOOS questionnaire starting 1 week after initiation of treatment. This effect was significant for two of five KOOS category scores, that is, "Pain" and "Daily Life" functioning, aggregate pain, and functioning scores composed of complaint ratings for a wide variety of daily activities. These scores showed long-lasting improvement, and demonstrated that EM extract successfully reliefs knee OA pain and contributes to daily life functioning.
关节健康不佳给社会带来了沉重负担。数百万人患有某种形式的关节相关疾病或病症,其中最常见的是骨关节炎(OA)。据推测,鸡蛋壳膜(EM)在软骨再生和/或免疫调节(口服耐受)方面有效,因此可缓解关节炎常见受累关节的疼痛和僵硬。我们在一项双盲、安慰剂对照的EM干预研究中对这一假设进行了测试。在150名年龄在40 - 75岁且被诊断为膝关节OA的男性和女性志愿者中,75人被随机分配到EM干预组,75人被分配到安慰剂组。在12周内,受试者每天服用一粒含有300毫克EM或安慰剂的胶囊。主要的主要因变量包括研究开始6周后通过数字评分量表疼痛(NRS - P)进行的自我报告疼痛评分。作为次要因变量的是12周后收集的NRS - P分数,以及膝关节损伤和自我报告的骨关节炎结果评分(膝关节损伤和骨关节炎结果评分[KOOS])。两组的NRS - P分数以大致相同的速率下降,但只有EM从治疗开始1周后缓解了通过KOOS问卷获得的自我报告疼痛评分。这种效果在KOOS五个类别评分中的两个方面具有显著性,即“疼痛”和“日常生活”功能、总疼痛以及由各种日常活动的主诉评分组成的功能评分。这些评分显示出长期改善,并表明EM提取物成功缓解了膝关节OA疼痛并有助于日常生活功能。